Trial Profile
A Retrospective, Cohort study to evaluate the efficacy of Zoster Vaccine Live for the prevention of Shingles in adults aged 70-79 years in the United Kingdom
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2018
Price :
$35
*
At a glance
- Drugs Varicella zoster virus vaccine live (Primary)
- Indications Herpes zoster
- Focus Therapeutic Use
- 17 Sep 2018 New trial record
- 05 Sep 2018 Primary endpoint (The incidence rates of shingles in vaccinated and unvaccinated populations) has been met, according to the results published in the Vaccine
- 05 Sep 2018 Results published in the Vaccine